Raccolta per Argomento: COVID-19

L’infezione da Sars-Cov-2 rappresenta una sfida senza precedenti per la medicina moderna. Gli sforzi fatti per comprendere le caratteristiche microbiologiche del virus e le misure messe in atto per ridurre il numero di contagi hanno portato ad un parziale contenimento della malattia a livello mondiale. In questo breve documento sono contenuti alcuni elementi per l’adeguata gestione del caso sospetto in ambiente ospedaliero e territoriale al fine di ottimizzare manovre di contenimento e gestione del paziente…

Physical Interventions to Interrupt or Reduce the Spread of Respiratory Viruses

Viral epidemics or pandemics of acute respiratory infections like influenza or severe acute respiratory syndrome pose a global threat. Antiviral drugs and vaccinations may be insufficient to prevent their spread…

Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence- based guideline

On Mar. 11, 2020, the World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) a pan- demic. The worldwide spread of COVID-19 represents a profound threat to human health. Patients with COVID-19 present primarily with fever, cough, and myalgia or fatigue, and sometimes initially with predominantly gastrointestinal symptoms…

COVID-19: An executive report

At a time when Italy and all world is dramatically faced with the challenge of the SARS-Cov-2 infection, hitting many aspects of human civilization, Commissione Salute of the Accademia Nazionale dei Lincei felt that it is part of its social responsibility to provide the society at large with an Executive Summary of the current status of understanding of origin, pathogenesis, and treatment of COVID-19 pandemic…

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

Coronavirus disease 2019 (COVID-19), a viral respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may predispose patients to thrombotic disease, both in the venous and arterial circulations, due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis…

Considerations in prophylaxis and treatment of VTE in COVID-19 Patients

In the rapidly evolving management of seriously ill patients affected with coronavirus disease 2019 (COVID-19) there is usually insufficient evidence available to make true practice guidelines. The question responses represent the opinion of a group of venous specialists who have reviewed the currently available evidence and have communicated with specialists in high volume sites in the US and internationally…

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Solid data is lacking, but an emerging body of evidence suggests that COVID-19 may predispose patients to arterial and venous thrombotic disease, and that some of the therapies under investigation may pose distinct drug-drug interactions with common antithrombotic medications…

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

We report five cases of large-vessel stroke in patients younger than 50 years of age who presented to our health system in New York City. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was diagnosed in all five patients…

Documento ISO-SIN-SNO-SICVE- AINRANEU- ALICe Italia Odv: Ictus – COVID-19

La comunità scientifica desidera contribuire al governo di questa emergenza, proponendo un modello di gestione del paziente con ictus cerebrale acuto che tenga conto della nuova realtà epidemiologica e, soprattutto, della rimodulazione del setting in cui gli operatori sanitari, e in particolare i Neurologi coinvolti nella cura del paziente con ictus, sono chiamati ad operare…

Pneumopatia da COVID-19: il punto di vista del Medico Vascolare

Partendo dalle evidenze presenti in letteratura, lo scopo di questo articolo è analizzare i possibili meccanismi coinvolti nel processo coagulativo a seguito dell’infezione da COVID-19 e quali potrebbero essere le strategie terapeutiche vascolari da poter attuare…

Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence

We report a case-series of COVID-19 patients with pulmonary embolism (PE) in our institution. Lille University Hospital is the tertiary care center for the North-of-France, the 2nd French region in population density (189 p/km2), also considered as a “metabolic” area with high number of overweight patients. The study was approved by the Institutional data protection authority of Lille University Hospital…

Coronavirus COVID-19: quali implicazioni per la Cardiologia?

L’attuale grave epidemia, o forse pandemia, del nuovo coronavirus COVID-19 emerso in Cina a Wuhan alla fine del 2019 ha dimostrato di avere un devastante impatto planetario di salute pubblica. Le implicazioni cardiologiche del coronavirus COVID-19 sono tutt’altro che marginali e costituiscono l’occasione per richiamare l’attenzione del cardiologo sulle rilevanti interazioni tra infezioni da virus respiratori o altri agenti patogeni e rischio cardiovascolare…

Coronaviruses and the cardiovascular system: acute and long-term implications

The present COVID-19 outbreak emphasizes the need for greater awareness of the immediate and long-term cardiovascular implications of viral infection and the significant gaps in knowledge that future research will need to address…

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy